Office of Research & Development |
  |
Talk to the Veterans Crisis Line now
An official website of the United States government
Project Number: | I01BX000849-05A2 |
| Title: | Relaxin and PPAR gamma Activation for Liver Disease Treatment |
| Principal Investigator: | Robert G. Bennett |
| Location: | Omaha, NE |
| Congressional District Code: | 2 |
| Research Service: | Biomedical Laboratory R&D |
| Project Period: | April 2016 - March 2021 |
| FY 2021 Funding Amount: | $83,282 |
| Total Award Amount (all years): |
$1,475,845 |
| Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: DESCRIPTION (provided by applicant): Hepatic fibrosis is a progressive condition resulting from a number of causes, including hepatitis, alcohol abuse, and nonalcoholic steatohepatitis, which can ultimately lead to cirrhosis and liver failure. Cirrhosis affects 900,000 persons, and the underlying causes (alcohol abuse and hepatitis infection) are more prevalent in the veteran population. There are currently few treatment options. Our previous studies showed that the hormone relaxin i... |